NCT00100568View on ClinicalTrials.gov

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
HIV Infections
Interventions
DRUG

Efavirenz

600 mg tablet taken orally daily

DRUG

Lamivudine/zidovudine

150mg lamivudine/300mg zidovudine tablet taken orally twice daily

Trial Locations (2)

Unknown

Centre National Hospitalier de Fann, Dakar CIPRA CRS, Dakar

Institut d'Hygiène Sociale, Dakar CIPRA CRS, Dakar

All Listed Sponsors
collaborator

Initiative Senegalaise d'Acces aux Antiretroviraux (ISAARV)

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00100568 - Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal | Biotech Hunter | Biotech Hunter